Research programme: cocaine abuse immunotherapies - DrugAbuse Sciences
Alternative Names: ITACLatest Information Update: 24 Oct 2021
At a glance
- Originator The Scripps Research Institute
- Developer DrugAbuse Sciences
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cocaine-related disorders
Most Recent Events
- 29 May 2008 Discontinued - Preclinical for Cocaine abuse in USA (unspecified route)
- 21 Aug 2002 This programme is still in active development
- 22 Mar 2000 Preclinical development for Cocaine abuse in USA (Unknown route)